AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 174,800 shares, an increase of 157.8% from the March 31st total of 67,800 shares. Based on an average daily trading volume, of 2,200 shares, the short-interest ratio is currently 79.5 days.

AstraZeneca Stock Performance

AZNCF opened at $146.05 on Friday. The company’s fifty day moving average price is $133.16 and its two-hundred day moving average price is $131.00. AstraZeneca has a 1-year low of $118.16 and a 1-year high of $152.06.

AstraZeneca Increases Dividend

The firm also recently disclosed a dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, February 23rd were issued a dividend of $1.97 per share. This is an increase from AstraZeneca’s previous dividend of $0.93. The ex-dividend date of this dividend was Wednesday, February 21st. AstraZeneca’s dividend payout ratio is presently 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.